nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—GSR—embryo—colon cancer	0.016	0.18	CbGeAlD
Carmustine—GSR—renal system—colon cancer	0.0121	0.136	CbGeAlD
Carmustine—GSR—lymphoid tissue—colon cancer	0.0101	0.113	CbGeAlD
Carmustine—GSR—digestive system—colon cancer	0.00996	0.111	CbGeAlD
Carmustine—GSR—bone marrow—colon cancer	0.00918	0.103	CbGeAlD
Carmustine—GSR—vagina—colon cancer	0.00879	0.0984	CbGeAlD
Carmustine—GSR—liver—colon cancer	0.00742	0.083	CbGeAlD
Carmustine—GSR—lymph node—colon cancer	0.00569	0.0637	CbGeAlD
Carmustine—CYP1A2—renal system—colon cancer	0.00413	0.0462	CbGeAlD
Carmustine—CYP1A2—digestive system—colon cancer	0.00339	0.0379	CbGeAlD
Carmustine—CYP1A2—liver—colon cancer	0.00252	0.0282	CbGeAlD
Carmustine—Pneumonia—Irinotecan—colon cancer	0.00235	0.00258	CcSEcCtD
Carmustine—Thrombophlebitis—Capecitabine—colon cancer	0.00234	0.00257	CcSEcCtD
Carmustine—Stomatitis—Vincristine—colon cancer	0.00234	0.00256	CcSEcCtD
Carmustine—Diabetes mellitus—Capecitabine—colon cancer	0.00233	0.00256	CcSEcCtD
Carmustine—Swelling—Capecitabine—colon cancer	0.0023	0.00252	CcSEcCtD
Carmustine—Renal failure—Irinotecan—colon cancer	0.00229	0.00252	CcSEcCtD
Carmustine—Stomatitis—Irinotecan—colon cancer	0.00227	0.0025	CcSEcCtD
Carmustine—Pneumonia—Fluorouracil—colon cancer	0.00225	0.00247	CcSEcCtD
Carmustine—Eye pain—Capecitabine—colon cancer	0.00224	0.00246	CcSEcCtD
Carmustine—Neuropathy peripheral—Fluorouracil—colon cancer	0.00219	0.00241	CcSEcCtD
Carmustine—Stomatitis—Fluorouracil—colon cancer	0.00218	0.00239	CcSEcCtD
Carmustine—Urinary tract infection—Fluorouracil—colon cancer	0.00217	0.00239	CcSEcCtD
Carmustine—Amnesia—Capecitabine—colon cancer	0.00216	0.00237	CcSEcCtD
Carmustine—Hallucination—Vincristine—colon cancer	0.00214	0.00235	CcSEcCtD
Carmustine—Hypoaesthesia—Vincristine—colon cancer	0.00214	0.00235	CcSEcCtD
Carmustine—Connective tissue disorder—Vincristine—colon cancer	0.00211	0.00232	CcSEcCtD
Carmustine—Haemoglobin—Irinotecan—colon cancer	0.00211	0.00231	CcSEcCtD
Carmustine—Haemorrhage—Irinotecan—colon cancer	0.00209	0.0023	CcSEcCtD
Carmustine—Pulmonary embolism—Methotrexate—colon cancer	0.00208	0.00228	CcSEcCtD
Carmustine—Connective tissue disorder—Irinotecan—colon cancer	0.00206	0.00226	CcSEcCtD
Carmustine—Hyponatraemia—Capecitabine—colon cancer	0.00203	0.00223	CcSEcCtD
Carmustine—Diplopia—Capecitabine—colon cancer	0.00203	0.00223	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00203	0.00223	CcSEcCtD
Carmustine—Visual impairment—Irinotecan—colon cancer	0.00202	0.00222	CcSEcCtD
Carmustine—Haemoglobin—Fluorouracil—colon cancer	0.00202	0.00221	CcSEcCtD
Carmustine—Depressed level of consciousness—Methotrexate—colon cancer	0.00201	0.0022	CcSEcCtD
Carmustine—Haemorrhage—Fluorouracil—colon cancer	0.00201	0.0022	CcSEcCtD
Carmustine—Hypoaesthesia—Fluorouracil—colon cancer	0.002	0.00219	CcSEcCtD
Carmustine—Skin exfoliation—Methotrexate—colon cancer	0.00198	0.00218	CcSEcCtD
Carmustine—Face oedema—Capecitabine—colon cancer	0.00196	0.00215	CcSEcCtD
Carmustine—Flushing—Irinotecan—colon cancer	0.00194	0.00213	CcSEcCtD
Carmustine—Ataxia—Capecitabine—colon cancer	0.00191	0.00209	CcSEcCtD
Carmustine—Alopecia—Vincristine—colon cancer	0.0019	0.00209	CcSEcCtD
Carmustine—Coma—Methotrexate—colon cancer	0.0019	0.00209	CcSEcCtD
Carmustine—Mental disorder—Vincristine—colon cancer	0.00188	0.00207	CcSEcCtD
Carmustine—Neoplasm—Methotrexate—colon cancer	0.00188	0.00206	CcSEcCtD
Carmustine—Arrhythmia—Irinotecan—colon cancer	0.00187	0.00205	CcSEcCtD
Carmustine—Liver function test abnormal—Capecitabine—colon cancer	0.00187	0.00205	CcSEcCtD
Carmustine—Gynaecomastia—Methotrexate—colon cancer	0.00186	0.00204	CcSEcCtD
Carmustine—Alopecia—Irinotecan—colon cancer	0.00185	0.00203	CcSEcCtD
Carmustine—Hypokalaemia—Capecitabine—colon cancer	0.00184	0.00202	CcSEcCtD
Carmustine—Back pain—Vincristine—colon cancer	0.00181	0.00199	CcSEcCtD
Carmustine—Sepsis—Methotrexate—colon cancer	0.0018	0.00198	CcSEcCtD
Carmustine—Arrhythmia—Fluorouracil—colon cancer	0.00179	0.00197	CcSEcCtD
Carmustine—Muscular weakness—Capecitabine—colon cancer	0.00179	0.00196	CcSEcCtD
Carmustine—Alopecia—Fluorouracil—colon cancer	0.00177	0.00195	CcSEcCtD
Carmustine—Back pain—Irinotecan—colon cancer	0.00176	0.00194	CcSEcCtD
Carmustine—Dysphagia—Capecitabine—colon cancer	0.00175	0.00192	CcSEcCtD
Carmustine—Erythema—Fluorouracil—colon cancer	0.00175	0.00192	CcSEcCtD
Carmustine—Thrombophlebitis—Methotrexate—colon cancer	0.00174	0.00191	CcSEcCtD
Carmustine—Diabetes mellitus—Methotrexate—colon cancer	0.00173	0.0019	CcSEcCtD
Carmustine—Anaemia—Vincristine—colon cancer	0.00173	0.0019	CcSEcCtD
Carmustine—Agitation—Vincristine—colon cancer	0.00172	0.00189	CcSEcCtD
Carmustine—Anaemia—Irinotecan—colon cancer	0.00169	0.00185	CcSEcCtD
Carmustine—Leukopenia—Vincristine—colon cancer	0.00168	0.00184	CcSEcCtD
Carmustine—Pancytopenia—Capecitabine—colon cancer	0.00166	0.00183	CcSEcCtD
Carmustine—Vision blurred—Fluorouracil—colon cancer	0.00165	0.00181	CcSEcCtD
Carmustine—Neutropenia—Capecitabine—colon cancer	0.00164	0.0018	CcSEcCtD
Carmustine—Leukopenia—Irinotecan—colon cancer	0.00163	0.00179	CcSEcCtD
Carmustine—Convulsion—Vincristine—colon cancer	0.00162	0.00178	CcSEcCtD
Carmustine—Hypertension—Vincristine—colon cancer	0.00162	0.00177	CcSEcCtD
Carmustine—Anaemia—Fluorouracil—colon cancer	0.00161	0.00177	CcSEcCtD
Carmustine—Myalgia—Vincristine—colon cancer	0.00159	0.00175	CcSEcCtD
Carmustine—Hyperglycaemia—Capecitabine—colon cancer	0.00158	0.00173	CcSEcCtD
Carmustine—Hypertension—Irinotecan—colon cancer	0.00157	0.00173	CcSEcCtD
Carmustine—Pneumonia—Capecitabine—colon cancer	0.00157	0.00172	CcSEcCtD
Carmustine—Leukopenia—Fluorouracil—colon cancer	0.00156	0.00172	CcSEcCtD
Carmustine—Depression—Capecitabine—colon cancer	0.00156	0.00171	CcSEcCtD
Carmustine—Renal failure—Capecitabine—colon cancer	0.00153	0.00169	CcSEcCtD
Carmustine—Neuropathy peripheral—Capecitabine—colon cancer	0.00153	0.00168	CcSEcCtD
Carmustine—Oedema—Vincristine—colon cancer	0.00153	0.00168	CcSEcCtD
Carmustine—Stomatitis—Capecitabine—colon cancer	0.00152	0.00167	CcSEcCtD
Carmustine—Infection—Vincristine—colon cancer	0.00152	0.00167	CcSEcCtD
Carmustine—Urinary tract infection—Capecitabine—colon cancer	0.00152	0.00167	CcSEcCtD
Carmustine—Convulsion—Fluorouracil—colon cancer	0.00151	0.00166	CcSEcCtD
Carmustine—Confusional state—Irinotecan—colon cancer	0.0015	0.00165	CcSEcCtD
Carmustine—Thrombocytopenia—Vincristine—colon cancer	0.0015	0.00164	CcSEcCtD
Carmustine—Oedema—Irinotecan—colon cancer	0.00149	0.00163	CcSEcCtD
Carmustine—Myalgia—Fluorouracil—colon cancer	0.00149	0.00163	CcSEcCtD
Carmustine—Chest pain—Fluorouracil—colon cancer	0.00149	0.00163	CcSEcCtD
Carmustine—Infection—Irinotecan—colon cancer	0.00148	0.00162	CcSEcCtD
Carmustine—Thrombocytopenia—Irinotecan—colon cancer	0.00146	0.0016	CcSEcCtD
Carmustine—Anorexia—Vincristine—colon cancer	0.00146	0.0016	CcSEcCtD
Carmustine—Confusional state—Fluorouracil—colon cancer	0.00144	0.00158	CcSEcCtD
Carmustine—Hypotension—Vincristine—colon cancer	0.00143	0.00157	CcSEcCtD
Carmustine—Oedema—Fluorouracil—colon cancer	0.00143	0.00156	CcSEcCtD
Carmustine—Anorexia—Irinotecan—colon cancer	0.00142	0.00156	CcSEcCtD
Carmustine—Ataxia—Methotrexate—colon cancer	0.00142	0.00156	CcSEcCtD
Carmustine—Infection—Fluorouracil—colon cancer	0.00142	0.00155	CcSEcCtD
Carmustine—Haemoglobin—Capecitabine—colon cancer	0.00141	0.00155	CcSEcCtD
Carmustine—Haemorrhage—Capecitabine—colon cancer	0.0014	0.00154	CcSEcCtD
Carmustine—Thrombocytopenia—Fluorouracil—colon cancer	0.0014	0.00153	CcSEcCtD
Carmustine—Hypoaesthesia—Capecitabine—colon cancer	0.00139	0.00153	CcSEcCtD
Carmustine—Liver function test abnormal—Methotrexate—colon cancer	0.00139	0.00153	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00139	0.00153	CcSEcCtD
Carmustine—Tachycardia—Fluorouracil—colon cancer	0.00139	0.00153	CcSEcCtD
Carmustine—Hypotension—Irinotecan—colon cancer	0.00139	0.00153	CcSEcCtD
Carmustine—Insomnia—Vincristine—colon cancer	0.00138	0.00152	CcSEcCtD
Carmustine—Oedema peripheral—Capecitabine—colon cancer	0.00138	0.00152	CcSEcCtD
Carmustine—Connective tissue disorder—Capecitabine—colon cancer	0.00138	0.00151	CcSEcCtD
Carmustine—Paraesthesia—Vincristine—colon cancer	0.00137	0.00151	CcSEcCtD
Carmustine—Anorexia—Fluorouracil—colon cancer	0.00136	0.00149	CcSEcCtD
Carmustine—Visual impairment—Capecitabine—colon cancer	0.00135	0.00148	CcSEcCtD
Carmustine—Insomnia—Irinotecan—colon cancer	0.00135	0.00148	CcSEcCtD
Carmustine—Paraesthesia—Irinotecan—colon cancer	0.00134	0.00147	CcSEcCtD
Carmustine—Hypotension—Fluorouracil—colon cancer	0.00133	0.00146	CcSEcCtD
Carmustine—Decreased appetite—Vincristine—colon cancer	0.00133	0.00146	CcSEcCtD
Carmustine—Dyspnoea—Irinotecan—colon cancer	0.00133	0.00146	CcSEcCtD
Carmustine—Somnolence—Irinotecan—colon cancer	0.00132	0.00145	CcSEcCtD
Carmustine—Gastrointestinal disorder—Vincristine—colon cancer	0.00132	0.00145	CcSEcCtD
Carmustine—Eye disorder—Capecitabine—colon cancer	0.00131	0.00144	CcSEcCtD
Carmustine—Pain—Vincristine—colon cancer	0.00131	0.00143	CcSEcCtD
Carmustine—Constipation—Vincristine—colon cancer	0.00131	0.00143	CcSEcCtD
Carmustine—Flushing—Capecitabine—colon cancer	0.0013	0.00143	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0013	0.00143	CcSEcCtD
Carmustine—Decreased appetite—Irinotecan—colon cancer	0.00129	0.00142	CcSEcCtD
Carmustine—Insomnia—Fluorouracil—colon cancer	0.00129	0.00142	CcSEcCtD
Carmustine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00128	0.00141	CcSEcCtD
Carmustine—Paraesthesia—Fluorouracil—colon cancer	0.00128	0.00141	CcSEcCtD
Carmustine—Pain—Irinotecan—colon cancer	0.00127	0.0014	CcSEcCtD
Carmustine—Constipation—Irinotecan—colon cancer	0.00127	0.0014	CcSEcCtD
Carmustine—Dyspnoea—Fluorouracil—colon cancer	0.00127	0.0014	CcSEcCtD
Carmustine—Somnolence—Fluorouracil—colon cancer	0.00127	0.00139	CcSEcCtD
Carmustine—Arrhythmia—Capecitabine—colon cancer	0.00125	0.00138	CcSEcCtD
Carmustine—Gastrointestinal pain—Vincristine—colon cancer	0.00125	0.00137	CcSEcCtD
Carmustine—Decreased appetite—Fluorouracil—colon cancer	0.00124	0.00136	CcSEcCtD
Carmustine—Alopecia—Capecitabine—colon cancer	0.00124	0.00136	CcSEcCtD
Carmustine—Pancytopenia—Methotrexate—colon cancer	0.00124	0.00136	CcSEcCtD
Carmustine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00123	0.00135	CcSEcCtD
Carmustine—Mental disorder—Capecitabine—colon cancer	0.00123	0.00135	CcSEcCtD
Carmustine—Feeling abnormal—Irinotecan—colon cancer	0.00123	0.00135	CcSEcCtD
Carmustine—Erythema—Capecitabine—colon cancer	0.00122	0.00134	CcSEcCtD
Carmustine—Malnutrition—Capecitabine—colon cancer	0.00122	0.00134	CcSEcCtD
Carmustine—Neutropenia—Methotrexate—colon cancer	0.00122	0.00134	CcSEcCtD
Carmustine—Pain—Fluorouracil—colon cancer	0.00122	0.00134	CcSEcCtD
Carmustine—Gastrointestinal pain—Irinotecan—colon cancer	0.00122	0.00134	CcSEcCtD
Carmustine—Abdominal pain—Vincristine—colon cancer	0.00121	0.00133	CcSEcCtD
Carmustine—Body temperature increased—Vincristine—colon cancer	0.00121	0.00133	CcSEcCtD
Carmustine—Back pain—Capecitabine—colon cancer	0.00118	0.0013	CcSEcCtD
Carmustine—Body temperature increased—Irinotecan—colon cancer	0.00118	0.00129	CcSEcCtD
Carmustine—Abdominal pain—Irinotecan—colon cancer	0.00118	0.00129	CcSEcCtD
Carmustine—Feeling abnormal—Fluorouracil—colon cancer	0.00117	0.00129	CcSEcCtD
Carmustine—Pneumonia—Methotrexate—colon cancer	0.00117	0.00128	CcSEcCtD
Carmustine—Depression—Methotrexate—colon cancer	0.00116	0.00127	CcSEcCtD
Carmustine—Vision blurred—Capecitabine—colon cancer	0.00115	0.00126	CcSEcCtD
Carmustine—Tremor—Capecitabine—colon cancer	0.00114	0.00126	CcSEcCtD
Carmustine—Renal failure—Methotrexate—colon cancer	0.00114	0.00125	CcSEcCtD
Carmustine—Stomatitis—Methotrexate—colon cancer	0.00113	0.00124	CcSEcCtD
Carmustine—Anaemia—Capecitabine—colon cancer	0.00113	0.00124	CcSEcCtD
Carmustine—Body temperature increased—Fluorouracil—colon cancer	0.00113	0.00124	CcSEcCtD
Carmustine—Hypersensitivity—Vincristine—colon cancer	0.00113	0.00124	CcSEcCtD
Carmustine—Hypersensitivity—Irinotecan—colon cancer	0.0011	0.0012	CcSEcCtD
Carmustine—Asthenia—Vincristine—colon cancer	0.0011	0.0012	CcSEcCtD
Carmustine—Leukopenia—Capecitabine—colon cancer	0.00109	0.0012	CcSEcCtD
Carmustine—Asthenia—Irinotecan—colon cancer	0.00107	0.00117	CcSEcCtD
Carmustine—Hypertension—Capecitabine—colon cancer	0.00105	0.00116	CcSEcCtD
Carmustine—Hypersensitivity—Fluorouracil—colon cancer	0.00105	0.00115	CcSEcCtD
Carmustine—Haemoglobin—Methotrexate—colon cancer	0.00105	0.00115	CcSEcCtD
Carmustine—Diarrhoea—Vincristine—colon cancer	0.00105	0.00115	CcSEcCtD
Carmustine—Haemorrhage—Methotrexate—colon cancer	0.00104	0.00115	CcSEcCtD
Carmustine—Chest pain—Capecitabine—colon cancer	0.00104	0.00114	CcSEcCtD
Carmustine—Myalgia—Capecitabine—colon cancer	0.00104	0.00114	CcSEcCtD
Carmustine—Anxiety—Capecitabine—colon cancer	0.00104	0.00114	CcSEcCtD
Carmustine—Diarrhoea—Irinotecan—colon cancer	0.00102	0.00112	CcSEcCtD
Carmustine—Dizziness—Vincristine—colon cancer	0.00101	0.00111	CcSEcCtD
Carmustine—Visual impairment—Methotrexate—colon cancer	0.00101	0.0011	CcSEcCtD
Carmustine—Confusional state—Capecitabine—colon cancer	0.001	0.0011	CcSEcCtD
Carmustine—Oedema—Capecitabine—colon cancer	0.000996	0.00109	CcSEcCtD
Carmustine—Infection—Capecitabine—colon cancer	0.000989	0.00109	CcSEcCtD
Carmustine—Dizziness—Irinotecan—colon cancer	0.000984	0.00108	CcSEcCtD
Carmustine—Eye disorder—Methotrexate—colon cancer	0.000975	0.00107	CcSEcCtD
Carmustine—Diarrhoea—Fluorouracil—colon cancer	0.000975	0.00107	CcSEcCtD
Carmustine—Thrombocytopenia—Capecitabine—colon cancer	0.000975	0.00107	CcSEcCtD
Carmustine—Tachycardia—Capecitabine—colon cancer	0.000972	0.00107	CcSEcCtD
Carmustine—Vomiting—Vincristine—colon cancer	0.000971	0.00107	CcSEcCtD
Carmustine—Rash—Vincristine—colon cancer	0.000963	0.00106	CcSEcCtD
Carmustine—Dermatitis—Vincristine—colon cancer	0.000962	0.00106	CcSEcCtD
Carmustine—Headache—Vincristine—colon cancer	0.000957	0.00105	CcSEcCtD
Carmustine—Anorexia—Capecitabine—colon cancer	0.000949	0.00104	CcSEcCtD
Carmustine—Vomiting—Irinotecan—colon cancer	0.000946	0.00104	CcSEcCtD
Carmustine—Dizziness—Fluorouracil—colon cancer	0.000942	0.00103	CcSEcCtD
Carmustine—Rash—Irinotecan—colon cancer	0.000938	0.00103	CcSEcCtD
Carmustine—Dermatitis—Irinotecan—colon cancer	0.000937	0.00103	CcSEcCtD
Carmustine—Headache—Irinotecan—colon cancer	0.000932	0.00102	CcSEcCtD
Carmustine—Hypotension—Capecitabine—colon cancer	0.000931	0.00102	CcSEcCtD
Carmustine—Alopecia—Methotrexate—colon cancer	0.000922	0.00101	CcSEcCtD
Carmustine—Mental disorder—Methotrexate—colon cancer	0.000914	0.001	CcSEcCtD
Carmustine—Erythema—Methotrexate—colon cancer	0.000908	0.000998	CcSEcCtD
Carmustine—Malnutrition—Methotrexate—colon cancer	0.000908	0.000998	CcSEcCtD
Carmustine—Nausea—Vincristine—colon cancer	0.000908	0.000997	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000907	0.000996	CcSEcCtD
Carmustine—Vomiting—Fluorouracil—colon cancer	0.000906	0.000995	CcSEcCtD
Carmustine—Insomnia—Capecitabine—colon cancer	0.000901	0.000989	CcSEcCtD
Carmustine—Rash—Fluorouracil—colon cancer	0.000899	0.000987	CcSEcCtD
Carmustine—Dermatitis—Fluorouracil—colon cancer	0.000898	0.000986	CcSEcCtD
Carmustine—Paraesthesia—Capecitabine—colon cancer	0.000894	0.000982	CcSEcCtD
Carmustine—Headache—Fluorouracil—colon cancer	0.000893	0.00098	CcSEcCtD
Carmustine—Dyspnoea—Capecitabine—colon cancer	0.000888	0.000975	CcSEcCtD
Carmustine—Nausea—Irinotecan—colon cancer	0.000884	0.000971	CcSEcCtD
Carmustine—Back pain—Methotrexate—colon cancer	0.000879	0.000965	CcSEcCtD
Carmustine—Decreased appetite—Capecitabine—colon cancer	0.000866	0.000951	CcSEcCtD
Carmustine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00086	0.000944	CcSEcCtD
Carmustine—Vision blurred—Methotrexate—colon cancer	0.000856	0.00094	CcSEcCtD
Carmustine—Constipation—Capecitabine—colon cancer	0.000852	0.000935	CcSEcCtD
Carmustine—Pain—Capecitabine—colon cancer	0.000852	0.000935	CcSEcCtD
Carmustine—Nausea—Fluorouracil—colon cancer	0.000846	0.00093	CcSEcCtD
Carmustine—Anaemia—Methotrexate—colon cancer	0.00084	0.000922	CcSEcCtD
Carmustine—Feeling abnormal—Capecitabine—colon cancer	0.000821	0.000901	CcSEcCtD
Carmustine—Gastrointestinal pain—Capecitabine—colon cancer	0.000814	0.000894	CcSEcCtD
Carmustine—Leukopenia—Methotrexate—colon cancer	0.000813	0.000893	CcSEcCtD
Carmustine—Body temperature increased—Capecitabine—colon cancer	0.000787	0.000865	CcSEcCtD
Carmustine—Abdominal pain—Capecitabine—colon cancer	0.000787	0.000865	CcSEcCtD
Carmustine—Convulsion—Methotrexate—colon cancer	0.000787	0.000864	CcSEcCtD
Carmustine—Myalgia—Methotrexate—colon cancer	0.000773	0.000849	CcSEcCtD
Carmustine—Chest pain—Methotrexate—colon cancer	0.000773	0.000849	CcSEcCtD
Carmustine—Confusional state—Methotrexate—colon cancer	0.000748	0.000821	CcSEcCtD
Carmustine—Infection—Methotrexate—colon cancer	0.000737	0.000809	CcSEcCtD
Carmustine—Hypersensitivity—Capecitabine—colon cancer	0.000734	0.000806	CcSEcCtD
Carmustine—Thrombocytopenia—Methotrexate—colon cancer	0.000726	0.000797	CcSEcCtD
Carmustine—Asthenia—Capecitabine—colon cancer	0.000715	0.000785	CcSEcCtD
Carmustine—Anorexia—Methotrexate—colon cancer	0.000707	0.000776	CcSEcCtD
Carmustine—Hypotension—Methotrexate—colon cancer	0.000693	0.000761	CcSEcCtD
Carmustine—Diarrhoea—Capecitabine—colon cancer	0.000681	0.000748	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000675	0.000742	CcSEcCtD
Carmustine—Insomnia—Methotrexate—colon cancer	0.000671	0.000736	CcSEcCtD
Carmustine—Paraesthesia—Methotrexate—colon cancer	0.000666	0.000731	CcSEcCtD
Carmustine—Dyspnoea—Methotrexate—colon cancer	0.000661	0.000726	CcSEcCtD
Carmustine—Somnolence—Methotrexate—colon cancer	0.000659	0.000724	CcSEcCtD
Carmustine—Dizziness—Capecitabine—colon cancer	0.000659	0.000723	CcSEcCtD
Carmustine—Decreased appetite—Methotrexate—colon cancer	0.000644	0.000708	CcSEcCtD
Carmustine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00064	0.000703	CcSEcCtD
Carmustine—Pain—Methotrexate—colon cancer	0.000634	0.000696	CcSEcCtD
Carmustine—Vomiting—Capecitabine—colon cancer	0.000633	0.000695	CcSEcCtD
Carmustine—Rash—Capecitabine—colon cancer	0.000628	0.00069	CcSEcCtD
Carmustine—Dermatitis—Capecitabine—colon cancer	0.000627	0.000689	CcSEcCtD
Carmustine—Headache—Capecitabine—colon cancer	0.000624	0.000685	CcSEcCtD
Carmustine—Feeling abnormal—Methotrexate—colon cancer	0.000611	0.000671	CcSEcCtD
Carmustine—Gastrointestinal pain—Methotrexate—colon cancer	0.000606	0.000666	CcSEcCtD
Carmustine—Nausea—Capecitabine—colon cancer	0.000592	0.00065	CcSEcCtD
Carmustine—Abdominal pain—Methotrexate—colon cancer	0.000586	0.000644	CcSEcCtD
Carmustine—Body temperature increased—Methotrexate—colon cancer	0.000586	0.000644	CcSEcCtD
Carmustine—Hypersensitivity—Methotrexate—colon cancer	0.000546	0.0006	CcSEcCtD
Carmustine—Asthenia—Methotrexate—colon cancer	0.000532	0.000584	CcSEcCtD
Carmustine—Diarrhoea—Methotrexate—colon cancer	0.000507	0.000557	CcSEcCtD
Carmustine—Dizziness—Methotrexate—colon cancer	0.00049	0.000538	CcSEcCtD
Carmustine—Vomiting—Methotrexate—colon cancer	0.000471	0.000518	CcSEcCtD
Carmustine—Rash—Methotrexate—colon cancer	0.000467	0.000513	CcSEcCtD
Carmustine—Dermatitis—Methotrexate—colon cancer	0.000467	0.000513	CcSEcCtD
Carmustine—Headache—Methotrexate—colon cancer	0.000464	0.00051	CcSEcCtD
Carmustine—Nausea—Methotrexate—colon cancer	0.00044	0.000484	CcSEcCtD
